Insider Trading Alert - IRIX, SGA And RM Traded By Insiders

Friday, Sept. 4, 2015, 66 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $23.91 to $1,080,000.00.

Highlighted Stocks Traded by Insiders:

Iridex (IRIX) - FREE Research Report

Paragon Associates & Paragon Associates Ii Joint Venture, who is 10% Owner at Iridex, bought 10,304 shares at $6.81 on Sept. 4, 2015. Following this transaction, the 10% Owner owned 1.2 million shares meaning that the stake was boosted by 0.88% with the 10,304-share transaction.

The shares most recently traded at $6.96, up $0.15, or 2.14% since the insider transaction. Historical insider transactions for Iridex go as follows:

  • 4-Week # shares bought: 30,955
  • 4-Week # shares sold: 2,616
  • 12-Week # shares bought: 162,892
  • 12-Week # shares sold: 2,616
  • 24-Week # shares bought: 162,892
  • 24-Week # shares sold: 4,063

The average volume for Iridex has been 32,700 shares per day over the past 30 days. Iridex has a market cap of $68.6 million and is part of the health care sector and health services industry. Shares are down 20.23% year-to-date as of the close of trading on Friday.

IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases. The company has a P/E ratio of 8.0. Currently, there are no analysts who rate Iridex a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IRIX - FREE

TheStreet Quant Ratings rates Iridex as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, notable return on equity and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Iridex Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Humana, Pharma Stocks Sink as Healthcare is Worst Performing Sector Wednesday

Insider Trading Alert - SWHC, HES And IRIX Traded By Insiders

Insider Trading Alert - ININ, GSAT And IRIX Traded By Insiders

Insider Trading Alert - IRIX, SGA And SNFCA Traded By Insiders